Orogen Royalties Grants Stock Options

Orogen Royalties Inc. has announced the issuance of 2,000,000 incentive Stock Options. These options are distributed to the company’s directors, officers, employees, and consultants. The initiative is part of their Omnibus Equity Incentive Compensation Plan, which received approval from shareholders on June 27, 2025.

The Stock Options have a duration of five years and an exercise price set at $2.20. The vesting schedule spans three years, with 25% vesting immediately and the remaining 25% on each subsequent anniversary date of the grant. These measures are pending regulatory approval from the TSX Venture Exchange.

This move aligns with Orogen’s strategy in organic royalty creation and acquisitions on metal discoveries. The company remains engaged with various active projects through joint ventures.